The Zhitong Finance App learned that an analysis of insurance claim data found that if GLP-1 drugs for weight loss and diabetes were priced below $350 per month, payers — such as employers and plan sponsors — would achieve net savings due to reduced usage of related medical services.

Zhitongcaijing · 2d ago
The Zhitong Finance App learned that an analysis of insurance claim data found that if GLP-1 drugs for weight loss and diabetes were priced below $350 per month, payers — such as employers and plan sponsors — would achieve net savings due to reduced usage of related medical services.